Vesicular stomatitis virus G protein (VSV-G)-pseudotyped retroviral vectors
have become more feasible for clinical gene transfer protocols since stabl
e tetracycline (tet)-regulated packaging cell lines have become available.
Here, we analyzed superinfection interference in VSV-G-pseudotyped and clas
sic amphotropic packaging cell lines. No superinfection interference was ob
served in VSV-G-pseudotyped packaging cell lines. Thus, integrated retrovir
al vector genomes accumulated during culture. Similar results were obtained
with the amphotropic packaging cells, but to a lesser degree. In addition,
VSV-G packaging cells were susceptible to infection with vector particles
devoid of envelope proteins, which are produced by these cells in high tite
rs when VSV-G expression is suppressed by tetracycline. For both packaging
systems, superinfection could be blocked by azidothymidine (AZT). With rega
rd to safety, this study suggests that in clinical protocols amphotropic pr
oducer clones should be tested for superinfection interference and VSV-G pa
ckaging cells should always be cultured in the presence of AZT.